YM Biosciences News
Most Popular YM Biosciences Story
YM BioSciences inks deal to acquire Cytopia
Canada's YM BioSciences (YMI) is taking over Australia's Cytopia (CYTX), combining their cancer drug programs into a single pipeline in a $14 million merger deal. Every 11.73 shares of Cytopia will Read more...
Latest Headlines
- October 6, 2009
- December 5, 2008
- June 20, 2008
- January 17, 2008
- January 30, 2007
- September 26, 2006
- August 2, 2006
- April 26, 2006
- April 16, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
